Literature DB >> 11407700

Is disease severity in ankylosing spondylitis genetically determined?

J Hamersma1, L R Cardon, L Bradbury, S Brophy, I van der Horst-Bruinsma, A Calin, M A Brown.   

Abstract

OBJECTIVE: To assess the role of genes and the environment in determining the severity of ankylosing spondylitis.
METHODS: One hundred seventy-three families with >1 case of ankylosing spondylitis were recruited (120 affected sibling pairs, 26 affected parent-child pairs, 20 families with both first- and second-degree relatives affected, and 7 families with only second-degree relatives affected), comprising a total of 384 affected individuals. Disease severity was assessed by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and functional impairment was determined using the Bath Ankylosing Spondylitis Functional Index (BASFI). Disease duration and age at onset were also studied. Variance-components modeling was used to determine the genetic and environmental components contributing to familiality of the traits examined, and complex segregation analysis was performed to assess different disease models.
RESULTS: Both the disease activity and functional capacity as assessed by the BASDAI and the BASFI, respectively, were found to be highly familial (BASDAI familiality 0.51 [P = 10(-4)], BASFI familiality 0.68 [P = 3 x 10(-7)]). No significant shared environmental component was demonstrated to be associated with either the BASDAI or the BASFI. Including age at disease onset and duration of disease as covariates made no difference in the heritability assessments. A strong correlation was noted between the BASDAI and the BASFI (genetic correlation 0.9), suggesting the presence of shared determinants of these 2 measures. However, there was significant residual heritability for each measure independent of the other (BASFI residual heritability 0.48, BASDAI 0.36), perhaps indicating that not all genes influencing disease activity influence chronicity. No significant heritability of age at disease onset was found (heritability 0.18; P = 0.2). Segregation studies suggested the presence of a single major gene influencing the BASDAI and the BASFI.
CONCLUSION: This study demonstrates a major genetic contribution to disease severity in ankylosing spondylitis. As with susceptibility to ankylosing spondylitis, shared environmental factors play little role in determining the disease severity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407700     DOI: 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

1.  A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population.

Authors:  Muhammet Cinar; Hatice Akar; Sedat Yilmaz; Ismail Simsek; Mutlu Karkucak; Rahsan Ilıkci Sagkan; Aysel Pekel; Hakan Erdem; Ismail Yasar Avci; Cengizhan Acikel; Ugur Musabak; Yusuf Tunca; Salih Pay
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

Review 2.  Biomarker development for axial spondyloarthritis.

Authors:  Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal:  Nat Rev Rheumatol       Date:  2020-06-30       Impact factor: 20.543

3.  Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.

Authors:  Michael M Ward; Matthew R Hendrey; James D Malley; Thomas J Learch; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2009-07-15

Review 4.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

Review 5.  Genetics of ankylosing spondylitis--insights into pathogenesis.

Authors:  Matthew A Brown; Tony Kenna; B Paul Wordsworth
Journal:  Nat Rev Rheumatol       Date:  2015-10-06       Impact factor: 20.543

6.  Aberrant Methylation of miR-34b and IL-12B mRNA Promoters Contributes to the Reduced Severity of Ankylosing Spondylitis.

Authors:  Shan Meng; Shaoguang Fan; Yanmei Li; Donghua Xu; Xiufen Ma; Yuhua Su; Yajing Liu; Chunxiao Guan; Qiang Shu
Journal:  Biochem Genet       Date:  2021-01-29       Impact factor: 1.890

7.  Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism.

Authors:  Zhen Wu; Zhiming Lin; Qiujing Wei; Jieruo Gu
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

Review 8.  The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.

Authors:  Sjef van der Linden; Nurullah Akkoc; Matthew A Brown; Philip C Robinson; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

9.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

Review 10.  Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.